World leading Victorian medical researchers have pioneered a revolutionary new drug that will change how we treat blood cancers into the future and around the globe.
Minister for Health Jill Hennessy joined the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital today to announce the results of two clinical trials into venetoclax – the drug that virtually melts cancer away.
Venetoclax is a tablet drug that was developed based on the discovery of the protein BCL-2 at the Walter and Eliza Hall Institute of Medical Research in Melbourne. The drug treats cancer by reducing the activity of BCL-2.
Two recent international studies have delivered remarkable results for hard-to-treat patients with Chronic Lymphocytic Leukaemia and Mantle-Cell Lymphoma which will provide a major shift in cancer treatment.
When combined with other standard immunotherapy treatments, venetoclax has seen a high number of these blood cancer patients be cancer free.
The global MURANO study showed venetoclax should replace chemotherapy altogether when treating certain forms of blood cancer, with more than 80 per cent of patients showing little or no detectable trace of cancer in their blood.